QuickView for Tumour suppressor candidate 2 (biogroup)

1. Inducible expression of PrPC in mouse skeletal muscles
2. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
5. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens

There were no matches for Tumour suppressor candidate 2

1. Temozolomide in Treating Patients With Invasive Pituitary Tumors
2. The Etiology and Progression of Brain Tumors
3. Cancer Vaccine Targeting Brachyury Protein in Tumors
4. Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurr…
5. A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer